rac-Ruxolitinib-d9 (major)
CAS: 941688-05-7
Ref. 3D-RMB68805
| 1mg | To inquire | |
| 2mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Estimated delivery in United States, on Thursday 27 Jun 2024
Product Information
Name:
rac-Ruxolitinib-d9 (major)
CAS:
Description:
Ruxolitinib is a racemic analogue of the janus tyrosine kinase inhibitor Ruxolitinib and it is active specifically on sub-types JAK1 and JAK2 with IC50 values in the nanomolar range. JAK1 and JAK2 are kinases involved in the regulation of hematopoiesis. Clinically applied to the treatment of intermediate and high-risk myelofibrosis, ruxolitinib is usually well tolerated by patients.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
315.42 g/mol
Formula:
C17H9D9N6
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-RMB68805 rac-Ruxolitinib-d9 (major)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
